Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
YUTIQ for Chronic Noninfectious Uveitis Involving the Posterior Segment
CTR20191729Phase 3Completed
- Sponsor
- EyePoint Pharmaceuticals
- Start
- Sep 2019
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of fluocinolone in uveitis, sponsored by EyePoint Pharmaceuticals. Started Sep 2019; status: completed.
02
Drugs
fluocinolone
03
Conditions
uveitis
Beyond the preview
Go deeper on CTR20191729.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20191729.